FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/081734 [Registered on: 06/03/2025] Trial Registered Prospectively
Last Modified On: 04/03/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   preoperative nebulization with ketamine will be compared with lignocaine in patients undergoing general anaesthesia in prevention of sore throat. 
Scientific Title of Study   Comparison of preoperative nebulization with lignocaine versus ketamine in prevention of sore throat in patients undergoing general anaesthesia 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Shivani Sharma  
Designation  Junior Resident  
Affiliation  Maharishi Markandeshwar Medical College 
Address  Department of Anaesthesiology, 3rd floor Maharishi Markandeshwar Medical College and Hospital Kumarhatti Solan , Himachal Pradesh

Solan
HIMACHAL PRADESH
173229
India 
Phone  8628891048  
Fax    
Email  100shivani.sharma@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Balvir Singh Sekhon 
Designation  Professor 
Affiliation  Maharishi Markandeshwar Medical College 
Address  Department of Anaesthesiology, 3rd floor Maharishi Markandeshwar Medical College and Hospital Kumarhatti Solan , Himachal Pradesh

Solan
HIMACHAL PRADESH
173229
India 
Phone  9814030551  
Fax    
Email  drbsekhon@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Shivani sharma 
Designation  Junior Resident  
Affiliation  Maharishi Markandeshwar Medical College 
Address  Department of Anaesthesiology, 3rd floor Maharishi Markandeshwar Medical College and Hospital Kumarhatti Solan , Himachal Pradesh

Solan
HIMACHAL PRADESH
173229
India 
Phone  8628891048  
Fax    
Email  100shivani.sharma@gmail.com  
 
Source of Monetary or Material Support  
Maharishi Markandeshwar Medical College and Hospital, Kumarhatti, Solan, Himachal pradesh India 173229  
 
Primary Sponsor  
Name  Shivani Sharma 
Address  Department of Anaesthesiology, Third floor, Maharishi Markandeshwar Medical college and Hospital, kumarhatti solan. 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shivani Sharma  Maharishi Markandeshwar Medical College and Hospital  O.T Complex Department of Anaesthesiology, 3rd floor 301 Maharishi Markandeshwar Medical College and Hospital Kumarhatti Solan , Himachal Pradesh
Solan
HIMACHAL PRADESH 
08628891048

100shivani.sharma@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Maharishi markandeshwar medical college   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Ketamine + Normal Saline 0.9%  50 mg(1ml) Ketamine + Normal saline 0.9% (1ml) nebulisation will be given to patient 15 minutes prior shifting to O.T. 
Comparator Agent  Lignocaine 2% + Normal Saline 0.9% (1ml)   Lignocaine 2% (1ml)+ Normal saline 0.9% (1ml) nebulisation will be given to patient 15 minutes prior shifting to O.T. 
Intervention  Normal Saline 0.9%  Intensity of Post operative sore throat in patients undergoing general anesthesia with nebulization with Normal Saline, Ketamine and Lignocaine will be compared. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1) ASA grade 1 and 2
2) Age : Between the ages of 18 and 70, enrolled for elective surgery required for 2 hours of endotracheal intubation while under general anaesthesia.
 
 
ExclusionCriteria 
Details  1) Patient that decline for participation in trial.
2) Patient allergic to ketamine or lignocaine.
3) Patient cough or bucked during intubation and extubation.
4) BMI more than 35 kg/ meter square.
5) Patient with history of previous sore throat or taking steroids or analgesia in last 48 hours
6) COPD, asthma, neuromuscular disease, difficult intubation.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
To assess and compare the intensity of Post-Operative sore throat in patients with Pre-Operative nebulization with lignocaine and ketamine undergoing general anaesthesia with endotracheal intubation.  Hemodynamic variables will continued to be monitored at baseline to 4 hours, 6 hours, 12 hours and then 24 hours. 
 
Secondary Outcome  
Outcome  TimePoints 
To evaluate the hemodynamic alterations and side effects, such as sedation, dry mouth, nausea, cough and vomiting during the study.  24 hours 
 
Target Sample Size   Total Sample Size="300"
Sample Size from India="300" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   17/03/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Group K- It includes patients nebulized with ketamine 50 mg (1ml)+ Normal saline (1ml)
Group L- It includes patients nebulized with Lignocaine 2% (1ml) + Normal Saline (1ml)
Group C- It includes patients nebulized with Normal saline (2ml)
 
Close